Add BrightSurf on Google Email

Study shows ‘obesity paradox’ does not exist: waist-to-height ratio is a better indicator of outcomes in patients with heart failure than BMI

A new study published in the European Heart Journal shows that using waist-to-height ratio instead of BMI provides a clearer picture of patient outcomes in heart failure. The researchers found that greater adiposity is associated with worse outcomes, including high rates of hospitalization and reduced health-related quality of life.

SourceEuropean Society of Cardiology·JournalEuropean Heart Journal·TypeObservational study·DateMar 21, 2023

New trials show promising, minimally invasive procedure to treat resistant hypertension

A recent study published in JAMA demonstrates the effectiveness of a minimally invasive procedure called renal denervation (RDN) to treat uncontrolled hypertension. RDN uses ultrasound energy delivered through a small balloon to denervate the renal artery, reducing sympathetic nerve activity and decreasing blood pressure.

SourceOchsner Health System·JournalJournal of the American Medical Association·DateMar 16, 2023

A novel mechanism may be effective in patients with severe hypertriglyceridemia and prior episodes of acute pancreatitis

A phase 2 study found that ANGPTL3 inhibitor therapy reduced triglycerides by up to 70% in patients with severe hypertriglyceridemia who had previously experienced acute pancreatitis. The treatment, evicanumab-dgnb, also showed potential for cardiovascular prevention by reducing apolipoprotein B levels.

SourceThe Mount Sinai Hospital / Mount Sinai School of Medicine·JournalNature Medicine·TypeRandomized controlled/clinical trial·DateMar 9, 2023

Mass General Brigham study finds virtual care team strategy improved treatment for heart failure patients

A virtual care team consisting of physicians and pharmacists improved the adoption of life-saving therapies in patients with heart failure, leading to increased use of evidence-based treatments and better patient outcomes. The strategy was safe and effective, with comparable length of stay and safety events between the groups.

SourceMass General Brigham·JournalJournal of the American College of Cardiology·TypeRandomized controlled/clinical trial·DateMar 6, 2023

High-dose anticoagulation can reduce intubations and improve survival for hospitalized COVID-19 patients

High-dose anticoagulation reduces intubations and deaths by 30% in hospitalized COVID-19 patients, especially those with ARDS. The study found a significant reduction in mortality and need for ICU care among patients treated with therapeutic anticoagulation.

SourceThe Mount Sinai Hospital / Mount Sinai School of Medicine·JournalJournal of the American College of Cardiology·TypeRandomized controlled/clinical trial·DateMar 6, 2023

Alert banners dramatically increase prescribing rates of life-saving heart failure medication

Researchers at NYU Grossman School of Medicine found that automated systems with alert banners increased MRA therapy prescriptions for heart failure patients by 30%. The system aims to improve care and reduce costs by streamlining medical information in one place. The study tested two notification types, finding that banner-like alerts...

Transcatheter mitral valve repair in heart failure patients significantly reduces hospitalizations and improves survival

A new study shows that transcatheter mitral valve repair significantly reduces hospitalizations by almost 50 percent and death by nearly 30 percent in heart failure patients with severe mitral regurgitation. The procedure, using Abbott's MitraClip system, improves symptoms, reduces hospitalizations, and leads to longer survival.

SourceThe Mount Sinai Hospital / Mount Sinai School of Medicine·JournalNew England Journal of Medicine·TypeRandomized controlled/clinical trial·DateMar 5, 2023

Imaging the adolescent heart

A recent MRI study by the CNIC has established reference values for anatomical and functional parameters in adolescents' hearts, providing a crucial resource for clinical practice. The study involved 123 adolescents and aimed to fill the knowledge gap on 'normal' cardiac parameter values in this age group.

SourceCentro Nacional de Investigaciones Cardiovasculares Carlos III (F.S.P.)·JournalEClinicalMedicine·TypeRandomized controlled/clinical trial·DateMar 3, 2023

Obesity makes it harder to diagnose and treat heart disease

A new review paper from Mayo Clinic outlines how obesity impacts common tests used to diagnose heart disease, such as ECG, CT scan, MRI, and echocardiogram. The study highlights the need for alternative approaches to prevent weight gain in patients with heart disease.

SourceMayo Clinic·JournalJournal of the American College of Cardiology·DateFeb 28, 2023

Study shows one in 25 patients undergoing transesophageal echocardiography-guided transcatheter structural cardiac intervention suffered a major complication

A study analyzing over 12,000 patients found that transesophageal echocardiography-guided transcatheter structural cardiac interventions were associated with a major complication rate of 3.6%. The most frequently reported complication was gastrointestinal bleeding.

SourceUniversity of Alabama at Birmingham·JournalJournal of the American Society of Echocardiography·DateFeb 27, 2023

Cleveland Clinic study finds common artificial sweetener linked to higher rates of heart attack and stroke

A new study by the Cleveland Clinic found that high levels of erythritol, a popular artificial sweetener, are associated with an increased risk of heart attack and stroke. Researchers studied over 4,000 people and found those with higher blood erythritol levels were at elevated risk of experiencing a major adverse cardiac event.

SourceCleveland Clinic·JournalNature Medicine·DateFeb 27, 2023

The Texas Heart Institute delivers a new first in heart failure treatment using cell therapy

A new cell therapy has demonstrated significant benefits in improving the heart's pumping ability and reducing the risk of cardiovascular death, heart attack, or stroke in patients with chronic heart failure. The therapy, using mesenchymal precursor cells (MPCs), also showed a strong signal in reducing inflammation and improving microv...

SourceTexas Heart Institute·JournalJournal of the American College of Cardiology·TypeRandomized controlled/clinical trial·DateFeb 27, 2023

Does risk for heart disease start before birth?

Research highlights the intergenerational impact of prepregnancy heart health on offspring, with low pre-pregnancy cardiovascular health linked to pregnancy complications and higher risk for cardiovascular disease. Improving women's heart health before pregnancy could reduce these risks and have a positive impact on future generations.

SourceAmerican Heart Association·JournalCirculation·DateFeb 13, 2023

Heart failure places a great strain on healthcare

A multinational study of over 600,000 heart failure patients found that the disease is relatively fatal, with an average annual death rate of 13%, and results in high healthcare costs. The study also identified new treatment opportunities for heart failure with preserved left ventricular function.

SourceKarolinska Institutet·JournalHeart·TypeObservational study·DateFeb 13, 2023

New statement shows PCI without surgery on site is as safe as PCI with surgery on site

A new expert consensus statement proposes a revised PCI treatment algorithm that expands the type of cases that can be performed with no-SOS, considering operator experience and facility preparation. The statement highlights low rates of complications and similar outcomes to PCIs performed at surgical centers.

SourceSociety for Cardiovascular Angiography and Interventions·JournalJournal of the Society for Cardiovascular Angiography & Interventions·DateJan 30, 2023

Columbia researchers find link between serotonin and heart valve disease

A new study led by Columbia researchers discovered a link between serotonin and heart valve disease, specifically degenerative mitral regurgitation. The study found that patients taking selective serotonin reuptake inhibitors (SSRIs) were more likely to develop severe mitral regurgitation and require surgery at a younger age.

SourceColumbia University Irving Medical Center·JournalScience Translational Medicine·TypeExperimental study·DateJan 27, 2023

Hospitals without highest stroke care designation may miss them after heart procedure

A Michigan Medicine study found that hospitals with the highest stroke care designation reported significantly higher rates of stroke detection after TAVR. The study suggests that comprehensive stroke centers are better at detecting smaller strokes, but this does not necessarily mean they are finding more strokes overall.

SourceMichigan Medicine - University of Michigan·JournalJACC Cardiovascular Interventions·TypeData/statistical analysis·DateJan 23, 2023

Female and male hearts respond differently to stress hormone in mouse study

Researchers discovered that female and male mouse hearts react uniformly at first to noradrenaline but exhibit differences in recovery time, affecting electrical activity. These findings may contribute to arrhythmia susceptibility between men and women, offering new insights into sex-based responses to stress hormones.

SourceUniversity of California - Davis Health·JournalScience Advances·TypeExperimental study·DateJan 20, 2023

New data clarifies safe and effective treatment for patients with mitral valve disease

Recent national data analyzed by leading cardiology and cardiothoracic surgical researchers found that the rate of successful repair has reached over 90% in the US, with an extremely low risk of mortality across nearly all age ranges. A novel risk model was developed to predict 30-day outcomes based on patient health conditions.

SourceThe Society of Thoracic Surgeons·JournalThe Annals of Thoracic Surgery·TypeData/statistical analysis·DateJan 19, 2023

Comparison of diuretics shows no difference in heart failure survival

A large clinical trial supported by the National Institutes of Health found that two widely used diuretics, furosemide and torsemide, did not differ in improving patient survival when compared. The study suggests a need for better treatments for heart failure patients and highlights the importance of optimizing diuretic doses to improv...

SourceNIH/National Heart, Lung and Blood Institute·JournalJournal of the American Medical Association·DateJan 17, 2023

Shockwave intravascular lithotripsy-assisted TMVR shows promise for patients with severe stenosis and regurgitation

A new study reveals that shockwave intravascular lithotripsy (IVL)-assisted transcatheter mitral valve replacement (TMVR) can effectively treat severely calcified mitral valves in patients with severe stenosis and regurgitation. Post-procedural imaging showed progressive valve frame expansion, increased valve area, and resolution of MR.

SourceSociety for Cardiovascular Angiography and Interventions·JournalJournal of the Society for Cardiovascular Angiography & Interventions·DateJan 10, 2023

Nuclear medicine bone scan study identifies prevalence and outcomes of cardiac amyloidosis

A new study found that approximately three percent of all bone scan patients have markers of cardiac amyloidosis, which can lead to heart failure and increased mortality. The research highlights the importance of early diagnosis and treatment, as well as potential automated detection methods using machine-learning algorithms.

SourceSociety of Nuclear Medicine and Molecular Imaging·JournalJournal of Nuclear Medicine·DateJan 3, 2023

New pediatric investigation article reviews the potential of transcatheter pulmonary valve replacement for congenital heart disorders

The procedure requires thorough pre-procedural evaluation and assessment of anatomical and hemodynamic data. Long-term results indicate that TPVR can effectively restore RVOT function, while improving survival rates and reducing the need for reintervention across age groups. Vigilant testing is recommended to avoid rare but serious com...

SourceCactus Communications·JournalPediatric Investigation·TypeCommentary/editorial·DateJan 3, 2023

World cardiology leaders call for global action to reinvent randomized clinical trials

Cardiology organizations propose modernizing randomized clinical trials using streamlined approaches, digital technology, and real-world data to enhance efficiency, safety, and innovation. The goal is to improve patient care and address unmet medical needs, particularly for diverse populations.

SourceEuropean Society of Cardiology·JournalEuropean Heart Journal·TypeRandomized controlled/clinical trial·DateDec 16, 2022

Albert Einstein College of Medicine and Montefiore Health System receive $5.2 Million NIH grant to study heart failure in Hispanic populations

Researchers will investigate the relationship between heart function and aorta stiffness to identify risk factors for heart failure in Hispanics/Latinos, who are disproportionately affected by this condition. The study aims to develop new methods for predicting and preventing heart failure in underrepresented populations.

Blood-based metabolic signature outperforms standard method for predicting diet, disease risk

A new study found that a machine learning-based blood test can accurately predict an individual's entire diet over 19 food groups, outperforming traditional methods. The test, which uses molecular profiling, also identifies who is more likely to develop diabetes and cardiovascular disease based on each food group.

SourceMichigan Medicine - University of Michigan·JournalEuropean Heart Journal·TypeComputational simulation/modeling·DateDec 14, 2022

Patients with depression less likely to follow critical medication plan following heart procedure

A new study published in JAMA Network Open found that patients with depression are less likely to adhere to essential medical therapies following percutaneous coronary intervention (PCI). The study examined over 124,000 patients who underwent PCI and were diagnosed with depression, revealing a significant proportion of individuals with...

SourceUniversity of Pittsburgh·JournalJAMA·DateDec 12, 2022